Company / PP&E (Net)
Annexon, Inc. PP&E (Net) History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$12.6M
FY2024
5-year range
$1.9M / $17.8M
FY2020-FY2024
Trend
-14.5%
vs FY2023
Sector context
#91 of 195
Health Care
What the data says
At $13M, Annexon, Inc.'s pp&e (net) ranks #91 of 195 in the Health Care sector. PP&E (Net) has declined for 3 consecutive years, from $18M in FY2021 to $13M in FY2024.
Based on SEC 10-K filings.
$13M in FY2024 with a 5-year CAGR of +42.7%.
Declined from $17M to $13M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -10.9%
- 5-Year CAGR
- +42.7%
- 10-Year CAGR
- -
Sector benchmark
#91 of 195 in Health CareTop 47% of 195This company $12.6M Sector average $770.1M
▼
-98.4% below sector average
Key checks
Key Insights
- Annexon, Inc.'s pp&e (net) has declined for 3 consecutive years.
- 5-year CAGR of +42.7%, indicating consistent growth.
- In FY2024, pp&e (net) decreased 14.5% year-over-year.
- Ranks #91 out of 195 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2024 | $12.6M | -14.5% |
| FY2023 | $14.8M | -12.3% |
| FY2022 | $16.8M | -5.7% |
| FY2021 | $17.8M | +822.4% |
| FY2020 | $1.9M | -9.5% |
| FY2019 | $2.1M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026